Drugs / Other: bone marrow-derived mesenchymal stem cells
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT02561767 | Oct 2015 → Oct 2016 | acute kidney tubular necrosis | First Affiliated Hospital, Sun Yat-Sen University | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Other: bone marrow-derived mesenchymal stem cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02561767 ↗ |
| Known as | BM-MSCs | “BM-MSCs is harvested from third-party health volunteer donors.” NCT02561767 ↗ |
| Modality | Cell therapy | “allogeneic bone marrow-derived mesenchymal stem cells” NCT02561767 ↗ |
| Route | Intravenous | “is intravenously given” NCT02561767 ↗ |